UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017753
Receipt No. R000020563
Official scientific title of the study Study of medication adherence with antiemetic drug therapy in breast cancer patients receiving chemotherapy.
Date of disclosure of the study information 2015/06/05
Last modified on 2017/03/26 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study of medication adherence with antiemetic drug therapy in breast cancer patients receiving chemotherapy.
Title of the study (Brief title) Study of medication adherence with antiemetic drug therapy in breast cancer patients receiving chemotherapy.
Region
Japan

Condition
Condition Breast cancer
Classification by specialty
Breast surgery Nursing Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To clarify degree of taking medication adherence with antiemetic drug therapy in breast cancer's women receiving chemotherapy.
Basic objectives2 Others
Basic objectives -Others None
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The degree of taking medication adherence with antiemetic drug therapy
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria 1)agreement to participation
2)Understanding Japanese
3)Judged by Doctor
Key exclusion criteria 1)more than PS2
2)receiving radiotherapy at present
Target sample size 100

Research contact person
Name of lead principal investigator Rie Shoda
Organization Keio University
Graduate School of Health Management
Division name Nursing
Address Shinanomachi 35,Shinjuku,Tokyo
TEL 03-5363-3733
Email r.shoda@a3.keio.jp

Public contact
Name of contact person Rie Shoda
Organization Keio University Graduate School of Health Management
Division name Nursing
Address Shinanomachi 35,Shinjuku,Tokyo
TEL 03-5363-3733
Homepage URL
Email r.shoda@a3.keio.jp

Sponsor
Institute Keio University Graduate School of Health Management
Institute
Department

Funding Source
Organization Rie Shoda
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 05 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 05 Month 21 Day
Anticipated trial start date
2015 Year 06 Month 15 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
2016 Year 03 Month 31 Day
Date trial data considered complete
2016 Year 03 Month 31 Day
Date analysis concluded
2016 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information prospective study

Management information
Registered date
2015 Year 05 Month 31 Day
Last modified on
2017 Year 03 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020563